A phase I/IIa first-in-human study of PM1003 (anti-PD-L1 x 4-1BB bispecific antibody) in patients with advanced solid tumors

被引：0

作者：

Xue, J. ^{[1
]}

Sun, Y. ^{[2
]}

Li, D. ^{[3
]}

Guo, Y. ^{[1
]}

机构：

[1] Shanghai East Hosp, Tongji Univ, Sch Med, Med Oncol, Shanghai, Peoples R China

[2] Shandong First Med Univ, Phase I Clin Study Dept, Canc Hosp, Jinan, Peoples R China

[3] Shandong First Med Univ, Med Oncol, Canc Hosp, Jinan, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.2175

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1036P

引用

页码：S629 / S629

页数：1

共 50 条

[31] ATOR-1017, A 4-1BB ANTIBODY, DEMONSTRATES PROMISING SAFETY AND PROOF OF MECHANISM IN A FIRST-IN-HUMAN STUDY IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES [J].

Carneiro, Ana ;

Ambarkhane, Sumeet ;

Smith, Karin Enel ;

Ullenhag, Gustav ;

Schulz, Lena ;

Landstrom, Tova ;

Ellmark, Peter ;

Carlsson, Malin ;

Yachnin, Jeffrey .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 :A747-A747

[32] A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors [J].

Melero, Ignacio ;

Tanos, Tamara ;

Bustamante, Mariana ;

Sanmamed, Miguel F. ;

Calvo, Emiliano ;

Moreno, Irene ;

Moreno, Victor ;

Hernandez, Tatiana ;

Garcia, Maria Martinez ;

Rodriguez-Vida, Alejo ;

Tabernero, Josep ;

Azaro, Analia ;

Ponz-Sarvise, Mariano ;

Spanggaard, Iben ;

Rohrberg, Kristoffer ;

Guarin, Ernesto ;

Nuesch, Eveline ;

Davydov, Iakov I. ;

Ooi, Chiahuey ;

Duarte, Jose ;

Chesne, Evelyne ;

McIntyre, Christine ;

Ceppi, Maurizio ;

Canamero, Marta ;

Krieter, Oliver .

SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (695)

[33] Phase Ib/IIa safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced solid tumors [J].

Guo, Ye ;

Guo, Jun ;

Cheng, Ying ;

Wang, Zhen ;

Li, Yongsheng ;

Lv, Dongqing ;

Yin, Yongmei ;

Li, Guiling ;

Wu, Lingying ;

Huang, Yi ;

Wei, Shuqing ;

Shen, Lin ;

Duan, Huaxin ;

Cui, Jiuwei ;

Luo, Hong ;

Li, Xiumin ;

Nan, Kejun ;

Wang, Chunyan ;

Luo, Su-Xia ;

Liu, Ruonan .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

[34] A phase 1 first-in-human study of the novel anti-LLT1 antibody (ZM008) alone and in combination with anti-PD1 antibody in patients with advanced solid tumors. [J].

Ghosh, Maloy ;

Fuloria, Jyotsna ;

Garcia-Ribas, Ignacio ;

Rivera, Ildefonso Ismael Rodriguez ;

Vandross, Andrae Lavon ;

Hanna, Glenn J. ;

Tiwari, Anurag ;

Dubey, Ashvini Kumar ;

Bhattacharjee, Sanghamitra ;

Manjunath, Yogendra ;

Sureshbabu, Shalini Kashipathi .

JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (16_SUPPL) :TPS2688-TPS2688

[35] Study of PRS-344/S095012 a PD-L1/4-1BB bispecific antibody-Anticalin®-fusion in patients with solid tumors. [J].

Jungels, Christiane ;

Kotecki, Nuria ;

Calvo, Emiliano ;

Garralda, Elena ;

Price, Timothy ;

Zahn, Xiaojiang ;

Abbas, Atif ;

Mahnke, Lisa ;

Rauschning, Winrich ;

Morales-Kastresana, Aizea ;

Pattarini, Lucia ;

Bossenmaier, Birgit ;

Scholer-Dahirel, Alix ;

Demuth, Tim ;

Legrande, Julie .

CANCER RESEARCH, 2022, 82 (12)

[36] Preliminary safety, efficacy, and pharmacokinetics (PK) results of KN046 (bispecific anti-PD-L1/CTLA4) from a first-in-human study in subjects with advanced solid tumors. [J].

Coward, Jermaine ;

Ganju, Vinod ;

Behzadigohar, Ramin ;

Kwong, Kenneth ;

Xu, June ;

Van, Hardy ;

Kong, Paul ;

Yang, Fei ;

Chen, Lisa ;

Guo, Kangping ;

Liu, Mei ;

Zhu, Danming ;

Donato, Lara Kristina ;

Xu, Ting ;

Richardson, Gary Edward .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[37] Bispecific anti-PD-1/CTLA-4 antibody for advanced solid tumors [J].

Perez-Santos, Martin .

PHARMACEUTICAL PATENT ANALYST, 2020, 9 (05) :149-154

[38] A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies [J].

Piha-Paul, Sarina ;

Olwill, Shane A. ;

Hamilton, Erika ;

Tolcher, Anthony ;

Pohlmann, Paula ;

Liu, Stephen V. ;

Wurzenberger, Cornelia ;

Hasenkamp, Laura-Carolin ;

Hansbauer, Eva-Maria ;

Shroff, Rachna ;

Hurvitz, Sara ;

Krishnamurthy, Anuradha ;

Patnaik, Amita ;

Hahn, Noah ;

Kumar, Raman ;

Duerr, Manuela ;

Zettl, Markus ;

Aviano, Kayti ;

Matis, Louis ;

Bruns, Ingmar ;

Ku, Geoffrey .

CLINICAL CANCER RESEARCH, 2025, 31 (02) :288-298

[39] A first-in-human phase I study of FS222, a CD137/PD-L1 tetravalent bispecific antibody, in patients with advanced malignancies [J].

Garralda, E. ;

Melero, I. ;

de Velasco, G. ;

Moreno, V. ;

Oberoi, H. K. ;

Shepherd, C. ;

Jones, D. ;

Lakins, M. A. ;

Hurley, P. ;

Khambhatwala, S. ;

Long, D. ;

Kayitalire, L. .

ANNALS OF ONCOLOGY, 2021, 32 :S1454-S1454

[40] Bispecific anti-PD-L1/PD-1 antibodies for advanced solid tumors: a patent evaluation of US2019010232 [J].

Villa-Ruano, Nemesio ;

Guerrero-Gonzalez, Tayde ;

Gomez-Conde, Eduardo ;

Perez-Santos, Martin .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (10) :723-727

← 1 2 3 4 5 →